A detailed history of Jnba Financial Advisors transactions in Merck & Co., Inc. stock. As of the latest transaction made, Jnba Financial Advisors holds 5,788 shares of MRK stock, worth $578,047. This represents 0.07% of its overall portfolio holdings.

Number of Shares
5,788
Previous 5,836 0.82%
Holding current value
$578,047
Previous $722,000 9.0%
% of portfolio
0.07%
Previous 0.08%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$111.15 - $128.97 $5,335 - $6,190
-48 Reduced 0.82%
5,788 $657,000
Q2 2024

Jul 22, 2024

SELL
$123.8 - $132.96 $24,760 - $26,592
-200 Reduced 3.31%
5,836 $722,000
Q1 2024

Apr 26, 2024

SELL
$113.24 - $131.95 $39,067 - $45,522
-345 Reduced 5.41%
6,036 $796,000
Q4 2023

Feb 07, 2024

BUY
$100.18 - $109.02 $400 - $436
4 Added 0.06%
6,381 $695,000
Q3 2023

Nov 02, 2023

SELL
$102.95 - $114.33 $4,735 - $5,259
-46 Reduced 0.72%
6,377 $656,000
Q2 2023

Aug 03, 2023

BUY
$108.61 - $118.38 $5,430 - $5,919
50 Added 0.78%
6,423 $741,000
Q1 2023

May 01, 2023

SELL
$102.94 - $114.86 $49,308 - $55,017
-479 Reduced 6.99%
6,373 $678,000
Q4 2022

Feb 06, 2023

SELL
$87.44 - $112.11 $113,934 - $146,079
-1,303 Reduced 15.98%
6,852 $760,000
Q3 2022

Nov 07, 2022

SELL
$84.53 - $94.96 $20,878 - $23,455
-247 Reduced 2.94%
8,155 $702,000
Q2 2022

Jul 22, 2022

SELL
$83.49 - $94.64 $14,193 - $16,088
-170 Reduced 1.98%
8,402 $766,000
Q1 2022

Apr 29, 2022

SELL
$73.51 - $82.4 $18,156 - $20,352
-247 Reduced 2.8%
8,572 $703,000
Q4 2021

Feb 03, 2022

BUY
$72.28 - $90.54 $21,394 - $26,799
296 Added 3.47%
8,819 $676,000
Q3 2021

Nov 10, 2021

BUY
$71.68 - $78.83 $56,627 - $62,275
790 Added 10.22%
8,523 $640,000
Q2 2021

Aug 04, 2021

BUY
$70.31 - $77.77 $92,668 - $102,500
1,318 Added 20.55%
7,733 $601,000
Q1 2021

May 03, 2021

BUY
$68.86 - $81.11 $92,341 - $108,768
1,341 Added 26.43%
6,415 $494,000
Q4 2020

Jan 25, 2021

BUY
$71.77 - $79.65 $6,531 - $7,248
91 Added 1.83%
5,074 $415,000
Q3 2020

Nov 05, 2020

SELL
$73.18 - $82.95 $3,146 - $3,566
-43 Reduced 0.86%
4,983 $413,000
Q2 2020

Jul 24, 2020

BUY
$70.42 - $80.13 $3,521 - $4,006
50 Added 1.0%
5,026 $389,000
Q4 2019

Feb 10, 2020

BUY
$77.58 - $87.54 $12,800 - $14,444
165 Added 3.43%
4,976 $453,000
Q3 2019

Nov 01, 2019

BUY
$76.08 - $82.93 $10,879 - $11,858
143 Added 3.06%
4,811 $405,000
Q2 2019

Jul 26, 2019

BUY
$69.84 - $81.59 $41,065 - $47,974
588 Added 14.41%
4,668 $391,000
Q1 2019

May 01, 2019

BUY
$69.58 - $79.36 $107,501 - $122,611
1,545 Added 60.95%
4,080 $339,000
Q4 2018

Feb 07, 2019

SELL
$65.24 - $75.71 $420,210 - $487,648
-6,441 Reduced 71.76%
2,535 $194,000
Q3 2018

Nov 01, 2018

BUY
$57.69 - $67.84 $352,312 - $414,298
6,107 Added 212.86%
8,976 $637,000
Q1 2018

May 07, 2018

SELL
$50.96 - $59.23 $3,312 - $3,849
-65 Reduced 2.22%
2,869 $2.87 Million
Q4 2017

Jan 31, 2018

SELL
$51.62 - $61.64 $7,743 - $9,246
-150 Reduced 4.86%
2,934 $165,000
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $15,371 - $16,540
262 Added 9.28%
3,084 $197,000
Q2 2017

Aug 14, 2017

BUY
N/A
2,822
2,822 $181,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Jnba Financial Advisors Portfolio

Follow Jnba Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jnba Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Jnba Financial Advisors with notifications on news.